Lucile Blaise - Nov 15, 2022 Form 4/A - Amendment Insider Report for RESMED INC (RMD)

Role
President, Sleep & RC Business
Signature
Lucile Blaise, President, Sleep & Respiratory Care
Stock symbol
RMD
Transactions as of
Nov 15, 2022
Transactions value $
$503,182
Form type
4/A - Amendment
Date filed
11/18/2022, 06:18 PM
Date Of Original Report
Nov 16, 2022
Previous filing
Jul 15, 2022
Next filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability -$38.1K -169 -2.42% $225.18 6.82K Nov 15, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Award $541K +2.41K $224.58 2.41K Nov 16, 2022 ResMed Common Stock 2.41K $224.58 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Corrects transaction as disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/14/2018.
F2 Reflects corrected share beneficially owned.
F3 Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025.